Interdisciplinary Rheumatology: Rheumatology and Ophthalmology

Rheumatologists routinely express a desire for a better understanding of ophthalmology to enhance their care of patients whose rheumatologic diseases manifest with ophthalmic complications. Ophthalmologists feel the same, seeking to understand the systemic impacts that autoimmune diseases have for their patients. As part of the Interdisciplinary Rheumatology book series, Interdisciplinary Rheumatology: Rheumatology and Ophthalmology is a dialogue between expert rheumatologists and ophthalmologists that provides readers with the skills to diagnose and manage a range of inflammatory eye conditions in patients with both systemic rheumatic and ocular-limited disease. With knowledge from this book, rheumatologists and ophthalmologists will be better able to collaborate effectively in the care of these complex patients.

Dr. Laura J. Kopplin is Associate Professor of Ophthalmology at the University of Wisconsin-Madison School of Medicine and Public Health. She completed a fellowship in uveitis and ocular immunology at the Casey Eye Institute – Oregon Health & Science University and the Devers Eye Institute in Portland, Oregon. Her research interests include epidemiology and risk factors for inflammatory eye diseases, clinical trials of uveitis therapeutics, biomarkers for uveitis outcomes, and clinical management of ocular inflammatory disease. She is the Subcommittee Chair of the American Academy of Ophthalmology Preferred Practice Pattern – Uveitis Panel. She is also the co-host of Headlight in the Fog: The Uveitis Podcast.

Dr. Joanne Valeriano-Marcet is Professor of Medicine at the University of South Florida in Tampa, Florida. She completed her fellowship in rheumatology at Mount Sinai Medical Center. Her awards have included the Parker J. Palmer “Courage to Teach” Award for Program Director Excellence from the ACGME and the Outstanding GME Program Director Award from USF, and she has been named among the Best Doctors in America. She has published widely and served on the ACGME Working Group to develop the Rheumatology Milestones 2.0.